Cg. Hillebrant et al., CHANGES IN BILIARY LIPID OUTPUT AFTER INTERRUPTION OF PRAVASTATIN TREATMENT IN HUMANS, European journal of clinical investigation, 26(12), 1996, pp. 1160-1165
Citations number
32
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
The use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase i
nhibitors (e.g. pravastatin) has gradually increased in the treatment
of hypercholesterolaemia. By inhibiting HMG-CoA reductase (the rate-li
miting enzyme in cholesterol synthesis) activity, cholesterol synthesi
s in the Liver is reduced and the plasma level of cholesterol, especia
lly low-density lipoprotein (LDL)-cholesterol, is substantially lowere
d. Simultaneously, inhibition of HMG CoA reductase activity is associa
ted with increased synthesis and accumulation of larger amounts of HMG
CoA reductase enzyme protein. The main purpose of this study was to d
etermine if the cessation of pravastatin treatment causes a rapid incr
ease in the synthesis and biliary secretion of cholesterol, a conditio
n which might lead to a temporarily increased cholesterol saturation o
f bile. Nine patients undergoing surgery for stones in the common bile
duct were fitted with T-tubes in the common bile duct peroperatively;
the side arm of the T-tube was left open postoperatively, creating a
biliary fistula. All patients were given 6 days' treatment with pravas
tatin (20 mg b.i.d.) following the operation. Bile was collected from
the T-tube, in 12-h fractions during this period and for another 3 day
s after termination of the treatment. Plasma levels of lipoproteins an
d lathosterol - reflecting cholesterol synthesis - were determined on
several occasions. After cessation of pravastatin treatment, the plasm
a levels of total cholesterol and LDL-cholesterol increased by 21% and
33% respectively. High-density lipoprotein (HDL)-cholesterol did not
change. The plasma level of lathosterol was increased two- to fourfold
. Outputs of bile acids and phospholipids were significantly increased
(23% and 10% respectively) after termination of treatment, whereas th
e output of cholesterol was not significantly changed. Cholesterol sat
uration was reduced by 20%, from 175 +/- 37% to 140 +/- 19%, but this
change was not significant. The results indicate that, with the presen
t experimental model (biliary diversion), the synthesis and biliary se
cretion of bile acids seem to be largely dependent on the de novo synt
hesis of cholesterol in the liver, whereas the biliary output of chole
sterol is not.